World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 13

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

150

HTML

2811

Figures (1-3)

444

Tables (1-3)

532

Sum=3937

Publishing Process of This Article

Item

Count

Browse

Download

281

Sum=375

Apr 7, 2024 (publication date) through Aug 12, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Kita K, Burdowski A. Recent clinical trials and optical control as a potential strategy to develop microtubule-targeting drugs in colorectal cancer management. World J Gastroenterol 2024; 30(13): 1780-1790 [PMID: 38659489 DOI: 10.3748/wjg.v30.i13.1780]
URL:	https://www.wjgnet.com/1007-9327/full/v30/i13/1780.htm

Number	Citing Articles
1	Scott Kopetz, Valentina Boni, Ken Kato, Kanwal P. S. Raghav, Maria Vieito, Athanasios Pallis, Christina Habermehl, Abdul Siddiqui, Perrine Courlet, Willem Sloot, Sabine Raab-Westphal, Felix Hart, Ildefonso Rodriguez-Rivera. Precemtabart tocentecan, an anti-CEACAM5 antibody–drug conjugate, in metastatic colorectal cancer: a phase 1 trial. Nature Medicine 2025; doi: 10.1038/s41591-025-03843-z
2	Naresh Singh, Samantha Sharma. Photo-activated microtubule targeting drugs: Advancing therapies for colorectal cancer. World Journal of Gastroenterology 2024; 30(26): 3257-3260 doi: 10.3748/wjg.v30.i26.3257 Abstract(479) \| Core Tip(485) \| Full Article(HTML)(1735) \| Full Article with Cover (PDF)-574K(184) \| Audio-392K(18) \| Peer-Review Report-170K(71) \| Answering Reviewers-29K(85) \| Full Article (PDF)-349K(125) \| Full Article (XML)-46K(99) \| Times Cited (1) \| Total Visits (4001) \| Open
3	Hung-Yu Lin, Tsen-Ni Tsai, Kai-Cheng Hsu, Yu-Ming Hsu, Lin-Chien Chiang, Mohamed El-Shazly, Ken-Ming Chang, Yu-Hsuan Lin, Shang-Yi Tu, Tony Eight Lin, Ying-Chi Du, Yi-Chang Liu, Mei-Chin Lu. From Sea to Science: Coral Aquaculture for Sustainable Anticancer Drug Development. Marine Drugs 2024; 22(7): 323 doi: 10.3390/md22070323